Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.

Live updates

1. 6d ago

   Boston Scientific Misses Guidance After Cyberattack

   Boston Scientific warns it will likely miss its third-quarter and full-year 2026 earnings guidance following a cyberattack that disrupted operations. The company has resumed shipping products after the cybersecurity incident, but financial analysts expect a material impact on results. In response to the warning, the company's stock fell, trading near USD 44.98 on September 8, 2026. Financial firm BTIG responded to the disruption by lowering its stock price target from USD 60 to USD 56 while maintaining a Buy rating.

   Why it matters

   Cybersecurity incidents continue to pose significant operational and financial risks to major healthcare and medical device manufacturers. When critical supply chains or shipping operations face sudden halts, companies frequently experience immediate negative pressure on quarterly guidance and share value. Market analysts watch these disruptions closely to measure how quickly firms can restore normal business functions.

   What is confirmed

   • Boston Scientific stated it is unlikely to meet its earnings guidance following a cyberattack.
   • The company has resumed shipping products after the cyberattack.
   • Boston Scientific stock traded near USD 44.98 as of September 8, 2026.
   • BTIG lowered its Boston Scientific stock price target from USD 60 to USD 56 on September 9, 2026, while keeping a Buy rating.

   What to watch next

   • Updates on the full financial magnitude of the material impact on upcoming quarterly results
   • Further adjustments to price targets or ratings by financial institutions
   Sources used for this update (6)

   1. Bloomberg.com — Boston Scientific Unlikely to Meet Forecasts After Cyber Attack
   2. Barron's — Boston Scientific ‘Unlikely to Meet’ Earnings Guidance After Cyberattack. Stock Falls.
   3. The Business Journals — Boston Scientific resumes shipping after cyberattack, but says it's 'unlikely' to hit growth target
   4. MassDevice — Boston Scientific could miss guidance over cybersecurity incident
   5. Fierce Biotech — Boston Scientific cyberattack likely to have ‘material impact’ on financial results
   6. www.ad-hoc-news.de — Boston Scientific stock falls as cyberattack prompts guidance cut and BTIG lowers price target
   confidence 100%